Performance incentives in community pharmacy can support timely dispensing, service availability, and organizational sustainability, yet their ethical acceptability depends on how performance expectations interact with pharmacists’ patient-safety obligations. This normative policy analysis examines the conditions under which dispensing targets and related productivity measures can coexist with independent clinical judgment. Drawing on evidence concerning pharmacy quality, dispensing safety, professional autonomy, organizational conditions, and incentive implementation, the analysis distinguishes legitimate performance coordination from arrangements that compromise essential clinical duties. It develops a framework grounded in proportionality, non-compensable safety obligations, effective professional discretion, institutional responsibility, and corrective accountability. The framework treats dispensing volume and service efficiency as permissible organizational objectives while requiring protected opportunities for clinical verification, patient counselling, justified interruption, and escalation of unsafe expectations. Organizational responsibility extends beyond setting targets to providing the resources, authority, and monitoring arrangements necessary for safe implementation. Incentive redesign must also distinguish reported safety concerns from measured harm and account for differences in pharmacy organization and regulatory jurisdiction. Performance incentives are ethically supportable when they remain subordinate to essential patient-safety duties, preserve meaningful clinical discretion, and incorporate enforceable mechanisms for identifying and correcting unsafe operational conditions.
